Compare AVTR & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | BCPC |
|---|---|---|
| Founded | 1904 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.6B |
| IPO Year | 2019 | 1995 |
| Metric | AVTR | BCPC |
|---|---|---|
| Price | $8.28 | $159.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 2 |
| Target Price | $12.42 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 8.9M | 186.8K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | 0.06 | ★ 1.25 |
| Revenue | ★ $6,552,200,000.00 | $799,023,000.00 |
| Revenue This Year | $1.05 | $8.47 |
| Revenue Next Year | $1.86 | $4.89 |
| P/E Ratio | $138.08 | ★ $128.46 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $7.27 | $139.17 |
| 52 Week High | $15.93 | $183.90 |
| Indicator | AVTR | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 32.02 |
| Support Level | $7.36 | $159.00 |
| Resistance Level | $8.67 | $160.65 |
| Average True Range (ATR) | 0.43 | 4.52 |
| MACD | 0.04 | -1.65 |
| Stochastic Oscillator | 58.99 | 11.68 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.